155 related articles for article (PubMed ID: 20621945)
1. Efficacy of an executive function intervention programme in MS: a placebo-controlled and pseudo-randomized trial.
Fink F; Rischkau E; Butt M; Klein J; Eling P; Hildebrandt H
Mult Scler; 2010 Sep; 16(9):1148-51. PubMed ID: 20621945
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a neuropsychological training programme for patients with multiple sclerosis -- a randomised controlled trial.
Tesar N; Bandion K; Baumhackl U
Wien Klin Wochenschr; 2005 Nov; 117(21-22):747-54. PubMed ID: 16416356
[TBL] [Abstract][Full Text] [Related]
3. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
[TBL] [Abstract][Full Text] [Related]
4. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
[TBL] [Abstract][Full Text] [Related]
5. Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial.
Solari A; Motta A; Mendozzi L; Pucci E; Forni M; Mancardi G; Pozzilli C;
J Neurol Sci; 2004 Jul; 222(1-2):99-104. PubMed ID: 15240203
[TBL] [Abstract][Full Text] [Related]
6. Effects of donepezil on memory and cognition in multiple sclerosis.
Christodoulou C; Melville P; Scherl WF; Macallister WS; Elkins LE; Krupp LB
J Neurol Sci; 2006 Jun; 245(1-2):127-36. PubMed ID: 16626752
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological functioning as a predictor of employment activity in a longitudinal study of HIV-infected adults contemplating workforce reentry.
Chernoff RA; Martin DJ; Schrock DA; Huy MP
J Int Neuropsychol Soc; 2010 Jan; 16(1):38-48. PubMed ID: 19765357
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location.
Reuter F; Zaaraoui W; Crespy L; Faivre A; Rico A; Malikova I; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Audoin B
Mult Scler; 2011 Jun; 17(6):755-8. PubMed ID: 21372116
[TBL] [Abstract][Full Text] [Related]
9. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
[TBL] [Abstract][Full Text] [Related]
10. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature.
O'Brien AR; Chiaravalloti N; Goverover Y; Deluca J
Arch Phys Med Rehabil; 2008 Apr; 89(4):761-9. PubMed ID: 18374010
[TBL] [Abstract][Full Text] [Related]
11. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures--an explorative study.
Filippi M; Riccitelli G; Mattioli F; Capra R; Stampatori C; Pagani E; Valsasina P; Copetti M; Falini A; Comi G; Rocca MA
Radiology; 2012 Mar; 262(3):932-40. PubMed ID: 22357892
[TBL] [Abstract][Full Text] [Related]
13. Thalamic atrophy and cognition in multiple sclerosis.
Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
[TBL] [Abstract][Full Text] [Related]
14. Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial.
Rilo O; Peña J; Ojeda N; Rodríguez-Antigüedad A; Mendibe-Bilbao M; Gómez-Gastiasoro A; DeLuca J; Chiaravalloti N; Ibarretxe-Bilbao N
Disabil Rehabil; 2018 Jan; 40(2):208-216. PubMed ID: 27927036
[TBL] [Abstract][Full Text] [Related]
15. Effects of a multifaceted treatment program for executive dysfunction after acquired brain injury on indications of executive functioning in daily life.
Spikman JM; Boelen DH; Lamberts KF; Brouwer WH; Fasotti L
J Int Neuropsychol Soc; 2010 Jan; 16(1):118-29. PubMed ID: 19900348
[TBL] [Abstract][Full Text] [Related]
16. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
17. A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.
Sastre-Garriga J; Alonso J; Renom M; Arévalo MJ; González I; Galán I; Montalban X; Rovira A
Mult Scler; 2011 Apr; 17(4):457-67. PubMed ID: 21177323
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease.
Narasimhalu K; Effendy S; Sim CH; Lee JM; Chen I; Hia SB; Xue HL; Corrales MP; Chang HM; Wong MC; Chen CP; Tan EK
Acta Neurol Scand; 2010 Apr; 121(4):217-24. PubMed ID: 19951274
[TBL] [Abstract][Full Text] [Related]
19. Cognitive training in MS: effects and relation to brain atrophy.
Hildebrandt H; Lanz M; Hahn HK; Hoffmann E; Schwarze B; Schwendemann G; Kraus JA
Restor Neurol Neurosci; 2007; 25(1):33-43. PubMed ID: 17473394
[TBL] [Abstract][Full Text] [Related]
20. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA
Menopause; 2006; 13(3):411-22. PubMed ID: 16735938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
